Stocks
REGENXBIO (RGNX) EBITDA margin US GAAP (year values) |
||||||||
| 2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | |||
| EBITDA margin, % | ? | -74.4% | 34.2% | -228.0% | -232.9% | -277.9% | -289.1% | |
| Changes by years, y/y, % | +486pp | +109pp | -262pp | -5pp | -45pp | |||
REGENXBIO. EBITDA margin, %
REGENXBIO. EBITDA margin, changes, pp
REGENXBIO (RGNX) EBITDA margin US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| EBITDA margin, % | ? | -345.3% | -343.6% | -224.5% | -268.2% | -368.6% | -289.1% | |
| Changes by years, y/y, % | -35pp | -161pp | +30pp | -84pp | -23pp | |||
| Changes by quarters, q/q, % | -161pp | +2pp | +119pp | -44pp | -100pp | |||
